Tsai YC - Search Results

1

The androgen receptor in bladder cancer.

Chen J, Huang CP, Quan C, Zu X, Ou Z, Tsai YC, Messing E, Yeh S, Chang C. Chen J, et al. Among authors: tsai yc. Nat Rev Urol. 2023 Sep;20(9):560-574. doi: 10.1038/s41585-023-00761-y. Epub 2023 Apr 18. Nat Rev Urol. 2023. PMID: 37072491 Review.

2

Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion.

Chen J, Sun Y, Ou Z, Yeh S, Huang CP, You B, Tsai YC, Sheu TJ, Zu X, Chang C. Chen J, et al. Among authors: tsai yc. EMBO Rep. 2020 Apr 3;21(4):e48467. doi: 10.15252/embr.201948467. Epub 2020 Feb 13. EMBO Rep. 2020. PMID: 32052578 Free PMC article.

3

Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts.

Yu S, Yeh CR, Niu Y, Chang HC, Tsai YC, Moses HL, Shyr CR, Chang C, Yeh S. Yu S, et al. Among authors: tsai yc. Prostate. 2012 Mar;72(4):437-49. doi: 10.1002/pros.21445. Epub 2011 Jul 7. Prostate. 2012. PMID: 21739465 Free PMC article.

4

Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo.

Hsu I, Yeh CR, Slavin S, Miyamoto H, Netto GJ, Tsai YC, Muyan M, Wu XR, Messing EM, Guancial EA, Yeh S. Hsu I, et al. Among authors: tsai yc. Oncotarget. 2014 Sep 15;5(17):7917-35. doi: 10.18632/oncotarget.1421. Oncotarget. 2014. PMID: 25277204 Free PMC article.

5

The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells.

Xu D, Lin TH, Zhang C, Tsai YC, Li S, Zhang J, Yin M, Yeh S, Chang C. Xu D, et al. Among authors: tsai yc. Prostate. 2012 May 15;72(7):803-16. doi: 10.1002/pros.21474. Epub 2011 Sep 19. Prostate. 2012. PMID: 21932429

6

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.

Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Chi KN, et al. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23. J Clin Oncol. 2023. PMID: 36952634 Free PMC article. Clinical Trial.

7

STAT1-Deficient HPV E6/E7-Associated Cancers Maintain Host Immunocompetency against Therapeutic Intervention.

Lim L, Hu MH, Fan D, Tu HF, Tsai YC, Cheng M, Wang S, Chang CL, Wu TC, Hung CF. Lim L, et al. Among authors: tsai yc. Vaccines (Basel). 2024 Apr 17;12(4):430. doi: 10.3390/vaccines12040430. Vaccines (Basel). 2024. PMID: 38675812 Free PMC article.

8

Better Performance of Modified Scoring Systems to Predict the Clinical Outcomes of Vibrio Bacteremia in the Emergency Department: An Observational Study.

Hsieh CM, Hu SY, Hsieh MS, Huang SC, Shen CH, Tsai YC. Hsieh CM, et al. Among authors: tsai yc. J Pers Med. 2024 Apr 3;14(4):385. doi: 10.3390/jpm14040385. J Pers Med. 2024. PMID: 38673012 Free PMC article.

9

FHL2 in arterial medial calcification in chronic kidney disease.

Liao YR, Tsai YC, Hsieh TH, Tsai MT, Lin FY, Lin SJ, Lin CC, Chiang HY, Chu PH, Li SY. Liao YR, et al. Among authors: tsai yc. Nephrol Dial Transplant. 2024 Apr 25:gfae091. doi: 10.1093/ndt/gfae091. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 38664060

10

Arginine-linked HPV-associated E7 displaying bacteria-derived outer membrane vesicles as a potent antigen-specific cancer vaccine.

Wang S, Chen CC, Hu MH, Cheng M, Tu HF, Tsai YC, Yang JM, Wu TC, Huang CH, Hung CF. Wang S, et al. Among authors: tsai yc. J Transl Med. 2024 Apr 22;22(1):378. doi: 10.1186/s12967-024-05195-7. J Transl Med. 2024. PMID: 38649894 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,534 results

Search Page